HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Traditional Chinese Medicine

677.343

+5.2390.78%

Number of Gainers:6

Number of Losers:5

Number of Flat:- -

PE:- -

High:680.384

Open:671.821

Low:670.484

Close:672.103

Volume:47.42M

Turnover:165.95M

Market Cap:69.79B

Float Cap:47.87B

Loading ...

Modern Chinese Medicine Turns to FY26 H1 Net Loss of RMB 25.9 Million; Revenue Rises 82.9% to RMB 118.5 Million

China Traditional Chinese Medicine Holdings Posts Wider Interim Net Loss

China Traditional Chinese Medicine Holdings H1 Net Income Attributable RMB -776.3 Million

THOMSON REUTERS

China TCM HY26 Loss Widens to RMB 834.7 Million; Revenue Drops 27.1% to RMB 5.44 Billion

Shandong Boan Biotech Files HKEX Next-Day Return Disclosing Share Buyback at HKD 3.74 Each

Tong Ren Tang Technologies Receives Official Registration for New Chinese Medicine Granules

Tong Ren Tang Chinese Medicine Clinches New Patent Medicine Sales Permit

Tong Ren Tang Technologies Inks E-Commerce Framework Agreement with Tong Ren Tang Digital Technology

Beijing Tongrentang Technologies Reports H1 Net Profit of RMB249 Million, Down 26.4% Year-on-Year

Tongrentang Chinese Medicine Reports Interim Results with Profit Dip to HK$198 Million

Chinese Traditional Medicine Maker Tong Ren Tang Profit Falls on Weaker Demand

Tong Ren Tang Chinese Medicine Wins Hong Kong Registration for Sanzi Yangqin Keli Product

Tong Ren Tang Technologies Signs New E-Commerce Services Deal with Tong Ren Tang Shuzi Technology Through 2028

Tong Ren Tang Technologies H1 Net Income Attributable RMB 249.1 Million

THOMSON REUTERS

Tong Ren Tang Technologies - Board Does not Declare the Distribution of an Interim Dividend

THOMSON REUTERS

Tong Ren Tang Tech FY26 H1 Profit Attributable to Owners Drops 26.43% to RMB 249.14 Million; Revenue Falls 19.1% to RMB 3.02 Billion

China's Dawnrays Pharmaceutical H1 Revenue Falls on Lower Procurement Prices

Guangzhou Baiyunshan Pharmaceutical - Disposal of First New Underlying Assets of Gp Corp. to Industrial Securities Asset Management for Rmb146.3 Mln

THOMSON REUTERS

Baiyunshan's First-Half Profit Plunges 16.7%: Herbal Tea Business Under Pressure, Lingering Legal Battle Over Jinge Resurfaces

China's Gushengtang Holdings HY Revenue Rises on Offline Medical Institution Expansion

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au.etasphere.com/stock/BK1606/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"BK1606","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1606\",,,,,undefined,":{"symbol":"BK1606","market":"HK","secType":"PLATE","nameCN":"Traditional Chinese Medicine","latestPrice":677.3426,"timestamp":1787904511585,"preClose":672.10315,"halted":0,"volume":47420260,"delay":0,"changeRate":0.007796,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":5.239441,"latestTime":"08-28 16:00:00","open":671.8213,"high":680.3837,"low":670.484,"amount":165952055,"amplitude":0.014729,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788139800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1787880600000,1787889600000],[1787893200000,1787904000000]],"pbRate":0.695189,"peRate":12.446339,"turnoverRate":0.003033,"increases":6,"decrements":5,"flats":0,"marketCap":69793151680,"floatMarketCap":47870260928},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1606\",,,,,undefined,":{"symbol":"BK1606","high":680.3837,"amplitude":0.014729,"preClose":672.10315,"low":670.484,"pbRate":"0.695189","latestPrice":677.3426,"volume":47420260,"delay":0,"open":671.8213,"prevYearClose":830.6915,"prevWeekClose":670.499,"prevMonthClose":681.608,"prevQuarterClose":629.733,"fiveDayClose":670.499,"twentyDayClose":681.608,"sixtyDayClose":730.04,"secType":"PLATE","market":"HK","turnoverRate":0.003033,"peRate":12.446339,"marketCap":69793151680,"floatMarketCap":47870260928,"timestamp":1787904511585,"nameCN":"Traditional Chinese Medicine"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1606\",,,,undefined,":{"bkCode":"BK1606","up":6,"down":5,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1606\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662095590","title":"Modern Chinese Medicine Turns to FY26 H1 Net Loss of RMB 25.9 Million; Revenue Rises 82.9% to RMB 118.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662095590","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662095590?lang=en_us&edition=fundamental","pubTime":"2026-08-28 21:13","pubTimestamp":1787922794,"startTime":"0","endTime":"0","summary":"Modern Chinese Medicine turns to FY26 H1 net loss of RMB 25.9 million; revenue rises 82.9% to RMB 118.5 millionModern Chinese Medicine posted a loss attributable to owners of RMB 25.9 million for the ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL1lvdv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01643","BK1606","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180189432","title":"China Traditional Chinese Medicine Holdings Posts Wider Interim Net Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=1180189432","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180189432?lang=en_us&edition=fundamental","pubTime":"2026-08-28 21:00","pubTimestamp":1787922017,"startTime":"0","endTime":"0","summary":"China Traditional Chinese Medicine Holdings (00570) has announced its interim results for the six months ended June 30, 2026, revealing a significant deterioration in financial performance.The...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1515","00570","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662060299","title":"China Traditional Chinese Medicine Holdings H1 Net Income Attributable RMB -776.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662060299","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662060299?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:06","pubTimestamp":1787918791,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nPLXGTR4HJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK1515","00570","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662060213","title":"China TCM HY26 Loss Widens to RMB 834.7 Million; Revenue Drops 27.1% to RMB 5.44 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2662060213","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662060213?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:06","pubTimestamp":1787918762,"startTime":"0","endTime":"0","summary":"China TCM HY26 loss widens to RMB 834.7 million; revenue drops 27.1% to RMB 5.44 billionChina Traditional Chinese Medicine posted a net loss of RMB 834.7 million, widening from RMB 141.8 million.Reven","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL7P9f4t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","00570","BK1191","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662585060","title":"Shandong Boan Biotech Files HKEX Next-Day Return Disclosing Share Buyback at HKD 3.74 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2662585060","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662585060?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:54","pubTimestamp":1787918088,"startTime":"0","endTime":"0","summary":"Shandong Boan Biotech files HKEX next-day return disclosing share buyback at HKD 3.74 eachShandong Boan Biotechnology repurchased 2,000,000 H shares on Aug. 28, held as treasury shares; cancelled shar","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL1NthNR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02186","06955","BK1583","BK1191","BK1161","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150868628","title":"Tong Ren Tang Technologies Receives Official Registration for New Chinese Medicine Granules","url":"https://stock-news.laohu8.com/highlight/detail?id=1150868628","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150868628?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:52","pubTimestamp":1787917934,"startTime":"0","endTime":"0","summary":"Tong Ren Tang Technologies (01666) has announced that its subsidiary, Beijing Tong Ren Tang Chinese Medicine Co., Ltd., has obtained a Certificate of Registration for Proprietary Chinese Medicine...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1606","BK1515","01666","BK1583","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163103018","title":"Tong Ren Tang Chinese Medicine Clinches New Patent Medicine Sales Permit","url":"https://stock-news.laohu8.com/highlight/detail?id=1163103018","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163103018?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:45","pubTimestamp":1787917500,"startTime":"0","endTime":"0","summary":"Tong Ren Tang Chinese Medicine Co Ltd has secured official clearance to distribute its newly formulated granule product across Hong Kong's pharmaceutical market. The company disclosed this...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1606","03613","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146624733","title":"Tong Ren Tang Technologies Inks E-Commerce Framework Agreement with Tong Ren Tang Digital Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=1146624733","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146624733?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:42","pubTimestamp":1787917334,"startTime":"0","endTime":"0","summary":"Tong Ren Tang Technologies (01666) has announced that on 28 August 2026, the company entered into an e-commerce services cooperation framework agreement with Tong Ren Tang Digital Technology. Under...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["600085","BK0028","BK0012","BK0183","LU1688375341.USD","BK0097","BK0113","BK0188","BK1191","BK1606","01666","BK0239","BK0086","BK1583","BK1515","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156513753","title":"Beijing Tongrentang Technologies Reports H1 Net Profit of RMB249 Million, Down 26.4% Year-on-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1156513753","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156513753?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:40","pubTimestamp":1787917216,"startTime":"0","endTime":"0","summary":"Beijing Tongrentang Technologies Co Ltd (HK: 01666) has announced its interim results for the six months ended June 30, 2026, revealing a 19.1% decline in revenue to RMB3.024 billion. The company's...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1583","BK1606","BK1515","01666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110638795","title":"Tongrentang Chinese Medicine Reports Interim Results with Profit Dip to HK$198 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1110638795","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110638795?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:37","pubTimestamp":1787917040,"startTime":"0","endTime":"0","summary":"TONGRENTANGCM (03613) has announced its interim results for the 2026 fiscal period, revealing a 15.6% year-on-year decline in profit attributable to shareholders, which settled at approximately...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","03613","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662829067","title":"Chinese Traditional Medicine Maker Tong Ren Tang Profit Falls on Weaker Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2662829067","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662829067?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:22","pubTimestamp":1787916148,"startTime":"0","endTime":"0","summary":"Chinese traditional medicine maker Tong Ren Tang profit falls on weaker demandOverviewHong Kong Chinese medicine maker's interim revenue fell 21% yr/yr to HK$601.9 mlnProfit attributable to owners dec","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL1N44P0DA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02407","BK0012","03737","BK1100","BK0239","BK1583","BK1191","03613","BK0183","600085","BK0086","01666","BK1515","BK0097","BK0196","LU1688375341.USD","00690","BK1606","BK0028","BK0113","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662091062","title":"Tong Ren Tang Chinese Medicine Wins Hong Kong Registration for Sanzi Yangqin Keli Product","url":"https://stock-news.laohu8.com/highlight/detail?id=2662091062","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662091062?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:20","pubTimestamp":1787916054,"startTime":"0","endTime":"0","summary":"Tong Ren Tang Chinese Medicine wins Hong Kong registration for Sanzi Yangqin Keli productTong Ren Tang Technologies unit Beijing Tong Ren Tang Chinese Medicine secured a Hong Kong registration certifi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL1vJZz8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","BK1515","600085","BK0028","LU1688375341.USD","BK0113","BK0239","BK1606","BK1191","BK0196","03613","BK0086","BK0097","BK0012","BK1583","01666","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662062782","title":"Tong Ren Tang Technologies Signs New E-Commerce Services Deal with Tong Ren Tang Shuzi Technology Through 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2662062782","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662062782?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:17","pubTimestamp":1787915879,"startTime":"0","endTime":"0","summary":"Tong Ren Tang Technologies signs new e-commerce services deal with Tong Ren Tang Shuzi Technology through 2028Tong Ren Tang Technologies signed a new e-commerce services framework agreement with Tong ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDLb5xfbZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0097","BK0086","600085","BK0188","BK1583","BK0028","01666","BK0196","BK1515","BK0239","LU1688375341.USD","BK1191","BK0012","BK0113","BK1606","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662062467","title":"Tong Ren Tang Technologies H1 Net Income Attributable RMB 249.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662062467","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662062467?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:13","pubTimestamp":1787915629,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nPLX14VWPQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","BK1515","BK1606","01666","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662062493","title":"Tong Ren Tang Technologies - Board Does not Declare the Distribution of an Interim Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2662062493","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662062493?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:13","pubTimestamp":1787915588,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nFWN44P0YW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","BK1191","BK1583","BK1606","01666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662706241","title":"Tong Ren Tang Tech FY26 H1 Profit Attributable to Owners Drops 26.43% to RMB 249.14 Million; Revenue Falls 19.1% to RMB 3.02 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2662706241","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662706241?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:13","pubTimestamp":1787915584,"startTime":"0","endTime":"0","summary":"Tong Ren Tang Tech FY26 H1 profit attributable to owners drops 26.43% to RMB 249.14 million; revenue falls 19.1% to RMB 3.02 billionTong Ren Tang Technologies posted a 26.43% drop in profit attributab","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL3f6wD5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0183","BK0086","BK0196","BK0097","LU1688375341.USD","BK1583","BK0239","01666","BK1606","BK0012","BK1515","BK0028","600085","BK0188","BK1191","BK0113"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662172061","title":"China's Dawnrays Pharmaceutical H1 Revenue Falls on Lower Procurement Prices","url":"https://stock-news.laohu8.com/highlight/detail?id=2662172061","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662172061?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:28","pubTimestamp":1787912881,"startTime":"0","endTime":"0","summary":"China's Dawnrays Pharmaceutical H1 revenue falls on lower procurement pricesOverviewChina pharmaceutical maker's interim revenue fell 13.4% yr/yr on lower sales of key productsProfit attributable to o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL1N44P0BX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1188198961.HKD","BK1161","LU0502904849.HKD","03737","LU2097828631.EUR","LU1969619763.USD","BK1583","LU2488822045.USD","HK0000165453.HKD","02348","BK1191","LU2242644610.SGD","01801","BK1589","LU0326950275.SGD","LU2097828557.USD","KURE","LU2097828714.EUR","BK1606","LU2097828474.EUR","LU2097828805.USD","LU0244354667.USD","LU0463099449.HKD","LU0455707207.USD","LU2328871848.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662406854","title":"Guangzhou Baiyunshan Pharmaceutical - Disposal of First New Underlying Assets of Gp Corp. to Industrial Securities Asset Management for Rmb146.3 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662406854","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662406854?lang=en_us&edition=fundamental","pubTime":"2026-08-28 16:48","pubTimestamp":1787906907,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nFWN44O1M2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","BK0175","BK0196","BK0097","00874","BK0096","BK0070","BK0188","BK1521","BK1606","BK1191","BK0028","BK0183","BK0239","600332","BK0012","BK1197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139991411","title":"Baiyunshan's First-Half Profit Plunges 16.7%: Herbal Tea Business Under Pressure, Lingering Legal Battle Over Jinge Resurfaces","url":"https://stock-news.laohu8.com/highlight/detail?id=1139991411","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139991411?lang=en_us&edition=fundamental","pubTime":"2026-08-28 14:31","pubTimestamp":1787898681,"startTime":"0","endTime":"0","summary":"Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA: 600332) has released its interim report for the first half of 2026, revealing a complex financial picture. The company recorded...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","BK0196","BK0097","BK0239","BK1197","BK0183","BK0012","BK1606","600332","BK1521","00874","BK0175","BK1191","BK0070","BK0096","BK1515","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662055140","title":"China's Gushengtang Holdings HY Revenue Rises on Offline Medical Institution Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2662055140","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662055140?lang=en_us&edition=fundamental","pubTime":"2026-08-28 12:25","pubTimestamp":1787891112,"startTime":"0","endTime":"0","summary":"China's Gushengtang Holdings HY revenue rises on offline medical institution expansionOverviewChina traditional medicine provider's half-year revenue rose 10.6% yr/yr to RMB1.65 blnNet profit attribut","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL1N44P04A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1606","01681","BK1191","BK1219","02273"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":58,"code":"91000000","status":"200"}]}}